Suppr超能文献

乳腺钼靶筛查项目中目前乳腺癌的可检测性。对间期癌和筛查发现癌的既往钼靶片回顾。

The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.

作者信息

van Dijck J A, Verbeek A L, Hendriks J H, Holland R

机构信息

Department of Medical Informatics and Epidemiology, University of Nijmegen, The Netherlands.

出版信息

Cancer. 1993 Sep 15;72(6):1933-8. doi: 10.1002/1097-0142(19930915)72:6<1933::aid-cncr2820720623>3.0.co;2-n.

Abstract

BACKGROUND

The occurrence of an interval cancer in a mammographic screening program is indicative of a suboptimum effect on mortality, because the very aim of the screening is to detect as many cancers as possible and at their earliest possible stage. In several studies, the previous screening mammograms of patients with an interval cancer were reviewed and the reasons for the "missed diagnosis" were classified into four categories: "screening error" (20-29%), "minimal sign present" (30-40%), "radiographically occult" (33-58%), or "radiographically occult at diagnosis" (occult both at previous screening and diagnosis; 7-16%). A similar procedure was followed in the Nijmegen screening project with patients recently diagnosed as having interval cancer or screen-detected cancer.

METHODS

The previous screening mammograms of 40 interval and 44 screen-detected cases from the breast cancer screening program in Nijmegen were reviewed and categorized as specified above. These breast cancers were diagnosed clinically before the patient was invited to the eighth screening round (interval cancer) or were detected at the eighth screening round (screen-detected cancer). All these patients had been screened in the seventh round (1987-88).

RESULTS

Thirteen percent of all cases were classified as "screening error," 38% as "minimal sign present," 43% as "radiographically occult," and 6% as "radiographically occult at diagnosis." In nearly half of the screen-detected cancers, minimal signs appeared to be present on the previous screening mammogram 2 years before the diagnosis.

CONCLUSIONS

Annual instead of biennial screening may advance detection in most of the "screening error" cases as well as in some in the categories "minimal sign present" and "radiographically occult" at the previous screening. Meticulous analysis of the radiologic characteristics of the "minimal sign present" cases may very well lead to results showing that earlier detection is possible without a significant decrease in the specificity of the screening test.

摘要

背景

在乳腺钼靶筛查项目中出现间隔期癌表明对死亡率的影响未达最佳,因为筛查的目的就是尽可能多地在癌症最早期阶段检测出癌症。在多项研究中,对间隔期癌患者之前的筛查乳腺钼靶片进行了回顾,并将“漏诊”原因分为四类:“筛查错误”(20 - 29%)、“存在微小征象”(30 - 40%)、“影像学隐匿”(33 - 58%)或“诊断时影像学隐匿”(在之前筛查和诊断时均隐匿;7 - 16%)。奈梅亨筛查项目对近期诊断为间隔期癌或筛查发现癌的患者采用了类似程序。

方法

回顾了奈梅亨乳腺癌筛查项目中40例间隔期癌和44例筛查发现癌患者之前的筛查乳腺钼靶片,并按上述分类。这些乳腺癌在患者被邀请参加第八轮筛查之前经临床诊断(间隔期癌),或在第八轮筛查时被检测出(筛查发现癌)。所有这些患者都参加了第七轮筛查(1987 - 1988年)。

结果

所有病例中,13%被归类为“筛查错误”,38%为“存在微小征象”,43%为“影像学隐匿”,6%为“诊断时影像学隐匿”。在近一半的筛查发现癌中,在诊断前2年的前一次筛查乳腺钼靶片上似乎存在微小征象。

结论

每年而非每两年进行一次筛查可能会在大多数“筛查错误”病例以及前一次筛查中“存在微小征象”和“影像学隐匿”类别中的一些病例中提前检测出癌症。对“存在微小征象”病例的放射学特征进行细致分析很可能会得出结果,表明有可能更早检测出癌症,而筛查试验的特异性不会显著降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验